OpenAI’s Fidji Simo Steps Down From No. 2 Role, Citing Chronic Illness

At a Glance:

• Fidji Simo, OpenAI’s CEO of Applications and the company’s de facto second-in-command, announced Thursday that she is stepping down from her full-time role.
• Simo cited a “severe exacerbation” of Postural Orthostatic Tachycardia Syndrome, a chronic neuroimmune condition she has managed since 2019.
• She will transition to a part-time advisory role focused on consumer products, advertising, and health applications rather than leave OpenAI entirely.
• Her responsibilities will be divided among OpenAI President Greg Brockman, CFO Sarah Friar, and Chief Strategy Officer Jason Kwon.

Fidji Simo, OpenAI’s chief of applications and widely regarded as Sam Altman’s top lieutenant, announced Thursday she is stepping down from her full-time executive role after an extended medical leave proved longer and more complicated than she initially expected.

Simo will remain connected to the company as a part-time adviser, according to Reuters, marking one of the most significant leadership changes at OpenAI since its recent confidential IPO filing and adding to a year already marked by notable executive turnover.

Why Simo Is Stepping Back

Simo disclosed in a post on X that she went on medical leave in April following a severe flare-up of Postural Orthostatic Tachycardia Syndrome, or POTS, a chronic neuroimmune condition affecting heart rate, blood flow, and energy levels that she was first diagnosed with in 2019. 

She wrote that three months of leave made clear her recovery would take considerably longer than anticipated, telling colleagues, “I am only making this decision now because I failed to make it many times before,” according to CNBC. 

Simo also reflected on turning down a full year of medical leave offered years earlier while at Meta, saying CEO Mark Zuckerberg had told her to “play the long game” and that she wished she had listened.

Who Takes Over and What Changes

OpenAI President Greg Brockman had already assumed responsibility for product decisions when Simo went on leave, a phase when three other execs resigned, and will continue to oversee that area. 

While Reuters reported that Chief Financial Officer Sarah Friar and Chief Strategy Officer Jason Kwon will divide the remainder of her applications portfolio between them. 

Simo joined OpenAI’s board in March 2024 before taking the newly created CEO of Applications role in May 2025, a position that brought Chief Operating Officer Brad Lightcap, Friar, and then-Chief Product Officer Kevin Weil all reporting directly to her, according to TechCrunch. 

As a part-time adviser, her focus will narrow to consumer products, advertising, and health-related applications, areas she has said she remains personally passionate about given her own experience navigating chronic illness.

Market Impact of Simo’s Move

Simo’s departure lands at a delicate moment for OpenAI as it works through the early stages of a potential public listing.

Immediate Market Reaction

OpenAI is a private company, so there was no direct stock market reaction to Simo’s announcement. 

Still, the news drew significant attention across the tech and business press given her stature as one of the highest-profile outside hires in OpenAI’s history and her position as one of Altman’s closest deputies.

Sector-Wide Implications

The departure adds to a broader pattern of ‘internal friction’ and executive churn at OpenAI, following the exit of Chief Marketing Officer Kate Rouch, who left to focus on her own cancer recovery. 

That pattern raises questions about organizational stability at a company recently valued at $852 billion and reportedly preparing for a future public offering, a process that typically demands a deep, settled executive bench.

Short-Term vs. Long-Term Impact

In the short term, Brockman, Friar, and Kwon will need to absorb Simo’s responsibilities without disrupting OpenAI’s product cadence, which included the same-day launch of its new GPT-5.6 model family and a new workplace agent called ChatGPT Work, according to TechCrunch. 

Longer term, OpenAI will need to determine whether a single successor eventually consolidates the application’s role Simo held or whether the divided structure among three executives becomes permanent.

Clear Breakdown of the Instability at OpenAI

Separating the personal and organizational elements of this story clarifies what’s actually changing at OpenAI.

What Changed

Simo’s full-time executive authority over OpenAI’s product and business operations has ended, replaced by a part-time advisory arrangement, while her direct reports and decision-making authority shift to three separate executives rather than a single successor.

What Stakeholders Should Do

Investors and partners tracking OpenAI’s path toward a public listing should watch how the company communicates its executive bench strength going forward, particularly given the string of recent senior departures beyond Simo’s exit.

Stakeholders must assess how this divided leadership structure will manage OpenAI’s massive $3.7 billion cash burn in Q1 2026, an eye-watering figure that remains a primary concern for the company’s long-term profitability.

What to Avoid

Avoid characterizing this as Simo leaving OpenAI entirely. Both CNBC and Reuters were clear that she is stepping back from full-time duties, not severing ties with the company, and will continue contributing in an advisory capacity.

Common Misconceptions About the Story

A couple of assumptions circulating this announcement deserve clarification.

“Simo’s Exit Signals Trouble With OpenAI’s IPO Plans”

Simo herself and OpenAI leadership have attributed the decision entirely to her health, not to any disagreement over strategy or IPO timing. OpenAI has said it isn’t targeting a public listing until at least next year, independent of this leadership change.

“OpenAI is halting product expansion because of Simo’s exit” 

The change signals the opposite. Simo’s massive portfolio was split among three top executives because product growth has accelerated, occurring the same day OpenAI launched its enterprise-focused ChatGPT Work agent.

Why Not to Rely on Social Media 

Social media reaction to Simo’s announcement has ranged from speculation about internal conflict to oversimplified takes that ignore the medical details she shared directly and publicly. 

Her own extended, personal explanation on X, along with confirmation from Sam Altman, provides far more reliable context than secondhand commentary circulating online.

What’s Your Take?

Does splitting Fidji Simo’s responsibilities among three executives show OpenAI has a deep leadership bench or reveal a gap needing a new hire?

How should fast-growing AI companies balance heavy executive workloads with supporting leaders who have serious chronic health conditions?

How This News Article Was Created

This business news report is built exclusively on:

• Official governance updates, advisory transitions, and leadership restructure details from Reuters, with health disclosures and internal communications verified via CNBC.
• Internal operational changes, executive portfolio breakdowns, and product launch timelines from TechCrunch.
• No confidential data or unreleased documents were used beyond verified publ